SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling

Cell Death & Disease, Published online: 25 January 2024; doi:10.1038/s41419-024-06476-1SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling

Source: Cell death and disease - January 25, 2024 Category: Internal Medicine Authors: Min Sun Mingjian Zhao Ruowen Li Yankun Zhang Xiaojia Shi Changyuan Ding Chunhong Ma Jinghui Lu Xuetian Yue Source Type: research